Which is the IDEAL Peginterferon for Hepatitis C: A Meta-Analysis of both Pegylated Interferons in the Treatment of HCV-Infected Patients

Author(s):
Frank TackeFrank Tacke1,*
1Department of Medicine III,RWTH-University Hospital Aachen, [email protected], Germany
*Corresponding Author: Department of Medicine III,RWTH-University Hospital Aachen, [email protected], Germany. Tel: +49 241 80 35848. Fax: +49 241 80 82455. Email: [email protected]

Hepatitis Monthly:Vol. 10, issue 3; 229-230
Published online:Sep 30, 2010
Article type:Letter
Received:Apr 13, 2010
Accepted:Apr 15, 2010
How to Cite:Tacke F. Which is the IDEAL Peginterferon for Hepatitis C: A Meta-Analysis of both Pegylated Interferons in the Treatment of HCV-Infected Patients. Hepat Mon. 2010;10(3):. doi:

Abstract

This article does not have abstract.

Keywords

Full Text

Full text is available in PDF

Copyright

© 2010, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Sep
2010

Efficacy of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV: Interpretation of Results and Future Prospects

Hossein Khedmat

Khedmat H. Efficacy of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV: Interpretation of Results and Future Prospects. Hepat Mon. 2010;10(3):. doi:

22
Nov
2014

Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?

Mohamad Amin Pourhoseingholi,
Sara Ashtari,
Seyed Moayed Alavian

Pourhoseingholi MA, Ashtari S, Alavian SM. Sofosbuvir vs. Combination of Pegylated Interferon and Ribavirin; How Much Shall Pay for Iranian Patients?. Hepat Mon. 2014;14(11):25540. doi: https://doi.org/10.5812/hepatmon.25540

30
Jun
2010

The Comparative Efficacy and Safety of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV Infection: A Meta-Analysis

Seyed Moayed Alavian,
Bita Behnava,
Seyed Vahid Tabatabaei

Alavian S, Behnava B, Tabatabaei S. The Comparative Efficacy and Safety of Peginterferon Alpha-2a vs. 2b for the Treatment of Chronic HCV Infection: A Meta-Analysis. Hepat Mon. 2010;10(2):. doi:

30
Sep
2010

Interferon-Based Therapy for Chronic Hepatitis C: Current and Future Perspectives

Valli De Re

Re V. Interferon-Based Therapy for Chronic Hepatitis C: Current and Future Perspectives. Hepat Mon. 2010;10(3):. doi:

30
Sep
2004

Optimal Therapy for Hepatitis C

Seyed Moayed Alavian

Alavian S. Optimal Therapy for Hepatitis C. Hepat Mon. 2004;4(7):. doi:

Download PDF281.43 KB
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC